Prevalence of Glucose Intolerance in Primary Hyperparathyroidism and the Benefit of Parathyroidectomy
Overview
Authors
Affiliations
Background: Increased prevalence of diabetes mellitus (DM) in primary hyperparathyroidism (PHPT) is established, but not glucose intolerance (GI), nor benefit from parathyroidectomy on GI. We determined these during management of a continuous series of patients with PHPT routinely followed after surgery.
Patients And Methods: WHO criteria classified 75 g oral glucose tolerance tests (OGTT) in 51/54 consecutively proven PHPT patients, into normal glucose tolerance (NGT), DM, impaired glucose tolerance (IGT) or impaired fasting glucose (IFG); GI was derived by adding those with DM and IGT/IFG. OGTT were repeated after parathyroidectomy (mean follow up 2.4 +/- SD 1.6 years). Paired student t tests were used to compare fasting and 2-h plasma glucose (PG).
Results: At presentation 32/54 patients (59%) had NGT, 10 IGT/IFG (19%) and 12 type 2 DM (22%), nine newly diagnosed. Before parathyroidectomy 17/35 patients had NGT (49%), 18 GI (51%), 12 DM (34%) and 6 IGT/IFG (17%). Five out of six patients with IGT/IFG had NGT, one with NGT developed IGT. At completion 23 patients (66%) had NGT, 12 GI (34%), 4 IGT/IFG (11%) and 8 DM (23%). After parathyroidectomy fasting and 2-h. PG fell in 30/34 normocalcaemic patients not on hypoglycaemic agents, 5.6 +/- 1.0 to 5.4 +/- 0.8 mmol/l, 7.2 +/- 3.0 to 6.3 +/- 3.1 mmol/l (p < 0.05, p < 0.01).
Conclusions: 1. At presentation with PHPT, OGTT commonly identifies Type 2 DM and GI.2. After successful parathyroidectomy fasting and 2-h. PG fall significantly (p < 0.05, p < 0.01). DM and IGT/IFG often ameliorates to IGT or NGT, persistently.
Barnett M Cureus. 2023; 15(6):e40743.
PMID: 37350980 PMC: 10284313. DOI: 10.7759/cureus.40743.
Parathyroid diseases and metabolic syndrome.
Modica R, Liccardi A, Minotta R, Benevento E, Cannavale G, Colao A J Endocrinol Invest. 2023; 46(6):1065-1077.
PMID: 36773188 PMC: 10185585. DOI: 10.1007/s40618-023-02018-2.
Effect of Parathyroidectomy on Metabolic Homeostasis in Primary Hyperparathyroidism.
Frey S, Bourgade R, Le May C, Croyal M, Bigot-Corbel E, Renaud-Moreau N J Clin Med. 2022; 11(5).
PMID: 35268464 PMC: 8911089. DOI: 10.3390/jcm11051373.
Nikooei Noghani S, Milani N, Afkhamizadeh M, Kabiri M, Bonakdaran S, Vazifeh-Mostaan L Endocrinol Diabetes Metab. 2021; 4(4):e00294.
PMID: 34505755 PMC: 8502214. DOI: 10.1002/edm2.294.
Yavari M, Feizi A, Haghighatdoost F, Ghaffari A, Rezvanian H Endocrine. 2020; 72(1):72-85.
PMID: 33057988 DOI: 10.1007/s12020-020-02519-7.